Hap Trading, LLC Crispr Therapeutics Ag Put Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 09, 2023	SELL	$45.39 - $59.0 $9,078 - $11,800	-200 Reduced 0.4%	50,400 $2.29 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $2.2 Million - $3.43 Million	50,600 New	50,600 $2.84 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $348,270 - $477,546	-5,700 Reduced 34.34%	10,900 $244,000
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $337,194 - $575,874	-7,800 Reduced 31.97%	16,600 $388,000
Q1 2022 May 12, 2022	SELL	$53.19 - $79.24 $287,226 - $427,896	-5,400 Reduced 18.12%	24,400 $741,000
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $336,432 - $534,192	4,800 Added 19.2%	29,800 $927,000
Q3 2021 Nov 10, 2021	SELL	$110.2 - $156.64 $716,300 - $1.02 Million	-6,500 Reduced 20.63%	25,000 $481,000
Q2 2021 Aug 11, 2021	BUY	$100.84 - $161.89 $211,764 - $339,969	2,100 Added 7.14%	31,500 $285,000
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $343,232 - $651,124	3,100 Added 11.79%	29,400 $737,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $318,680 - $692,920	4,000 Added 17.94%	26,300 $314,000
Q2 2020 Aug 10, 2020	BUY	$38.5 - $76.05 $323,400 - $638,820	8,400 Added 60.43%	22,300 $21,000
Q1 2020 May 08, 2020	SELL	$33.68 - $62.53 $296,384 - $550,264	-8,800 Reduced 38.77%	13,900 $121,000
Q4 2019 Feb 11, 2020	BUY	$36.68 - $73.13 $223,748 - $446,093	6,100 Added 36.75%	22,700 $64,000
Q3 2019 Nov 12, 2019	BUY	$40.99 - $52.56 $262,336 - $336,384	6,400 Added 62.75%	16,600 $72,000
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $230,425 - $313,300	-6,500 Reduced 38.92%	10,200 $22,000
Q1 2019 May 10, 2019	BUY	$28.02 - $40.87 $75,654 - $110,349	2,700 Added 19.29%	16,700 $54,000
Q3 2018 Nov 09, 2018	BUY	$44.35 - $65.71 $53,220 - $78,851	1,200 Added 9.38%	14,000 $105,000
Q2 2018 Aug 13, 2018	BUY	$42.62 - $73.59 $545,536 - $941,952	12,800 New	12,800 $36,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$367 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$347 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$139 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$137 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$137 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account